Immunotherapy Medications
Immunotherapy helps the immune system find and attack cancer cells, which can sometimes hide from immune cells or turn off natural immune responses. Some immunotherapies mark cancer cells and make them easier for the immune system to recognize. Others boost the activity of T cells or other immune cells against tumors.
*generic or biosimilar available
E experimental
DRUG Bavencio |
---|
|
GENERIC NAME avelumab |
COMPANY EMD Serono |
DRUG Imfinzi |
---|
|
GENERIC NAME durvalumab |
COMPANY AstraZeneca |
DRUG Keytruda |
---|
|
GENERIC NAME pembrolizumab |
COMPANY Merck |
DRUG Kymriah |
---|
|
GENERIC NAME tisagenlecleucel |
COMPANY Novartis |
DRUG Libtayo |
---|
|
GENERIC NAME cemiplimab-rwlc |
COMPANY Regeneron/ Sanofi |
DRUG Opdivo |
---|
|
GENERIC NAME nivolumab |
COMPANY Bristol-Myers Squibb |
DRUG Pomalyst |
---|
|
GENERIC NAME pomalidomide |
COMPANY Bristol Myers Squibb/Celgene |
DRUG Provenge |
---|
|
GENERIC NAME sipuleucel-T |
COMPANY Dendreon |
DRUG Revlimid |
---|
|
GENERIC NAME lenalidomide |
COMPANY Celgene |
DRUG Tecartus |
---|
|
GENERIC NAME brexucabtagene autoleucel |
COMPANY Kite/Gilead Sciences |
DRUG Tecentriq |
---|
|
GENERIC NAME atezolizumab |
COMPANY Genentech |
DRUG Thalomid* |
---|
|
GENERIC NAME thalidomide |
COMPANY Celgene |
DRUG TICE |
---|
|
GENERIC NAME Bacillus Calmette-Guerin |
COMPANY Merck/Organon Teknika |
DRUG Yervoy |
---|
|
GENERIC NAME ipilimumab |
COMPANY Bristol-Myers Squibb |
DRUG Yescarta |
---|
|
GENERIC NAME axicabtagene ciloleucel |
COMPANY Kite, a Gilead company |